Ryman HealthcareASX:RYM 53 9-Day RSI is 49.37 as of Jul. 01, 2026. GuruFocus rates ASX:RYM with a GF Score™ of 53/100. Among 700 Healthcare Providers & Services companies, Ryman Healthcare ranks worse than 68.14% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-01), Ryman Healthcare's 9-Day RSI is 49.37.
The industry rank for Ryman Healthcare's 9-Day RSI or its related term are showing as below:
ASX:RYM's 9-Day RSI is ranked worse than 68.14% of 700
companies
in the Healthcare Providers & Services industry
Industry Median: 49.325
vs ASX:RYM: 49.37
Ryman Healthcare (ASX:RYM) 9-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Ryman Healthcare 9-Day RSI Related Terms
ASX:RYM vs HCA, THC, DVA: 9-Day RSI Comparison
For the Medical Care Facilities subindustry, Ryman Healthcare's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ryman Healthcare 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ryman Healthcare's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Ryman Healthcare's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ryman Healthcare (ASX:RYM) has a 9-Day RSI of 49.37 as of Jul. 01, 2026. According to the industry distribution chart, Ryman Healthcare ranks #477 out of 700 companies in the Healthcare Providers & Services industry, placing it in the top 68.1%.
Is Ryman Healthcare's 9-Day RSI too high?
Ryman Healthcare's current 9-Day RSI is 49.37. The Healthcare Providers & Services industry median 9-Day RSI is 49.33. Ryman Healthcare's value of 49.37 is 0.1% above this industry median. Based on the distribution chart, Ryman Healthcare ranks #477 out of 700 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ryman Healthcare has a GF Score™ of 53/100, reflecting its overall financial health beyond just this single metric.
How does Ryman Healthcare's 9-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ryman Healthcare ranks #477 out of 700 companies for 9-Day RSI. This places Ryman Healthcare in the lower half of its industry. The industry median 9-Day RSI is 49.33. Ryman Healthcare's value of 49.37 is 0.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 49.33, based on 700 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ryman Healthcare's current 9-Day RSI of 49.37 is 0.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 49.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ryman Healthcare's current 9-Day RSI is 49.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ryman Healthcare stock overvalued right now?
Ryman Healthcare (ASX:RYM) has a current 9-Day RSI of 49.37. The current 9-Day RSI is 49.37 and 0.1% above the Healthcare Providers & Services industry median of 49.33. Ryman Healthcare's overall GF Score™ is 53/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Ryman Healthcare (ASX:RYM), the current 9-Day RSI is 49.37 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ryman Healthcare Ltd is a retirement living and aged care provider operating in New Zealand and Australia. It owns and operates integrated retirement villages through its trading subsidiaries, which operate in the aged care and retirement living sector in New Zealand and Australia. The Group operates in a single industry: the provision of integrated retirement living and aged care for older people in New Zealand and Australia. The majority of revenue is derived from Care and village fees, which relate to the provision of accommodation, care and related services to aged care residents and retirement living residents.
53GF Score
Get the complete analysis for ASX:RYM
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RYM has been successfully added to your 